Swiss Franc
Swiss equities slip on oil, Fed bets; Roche weighs on SMI
The Swiss Market Index fell 0.1% as Roche dragged, while Kühne+Nagel gained 1.4%. Brent crude rose 3.3% to $90.98 amid Middle East tensions and delayed Hormuz Strait talks.
Swiss stocks flat as oil rises, Fed rate hike bets weigh; Kühne+Nagel leads gains
The SMI traded little changed Monday as defensive stocks offset rising U.S. rate expectations and Brent crude topped $90 a barrel. Roche and Givaudan lagged while logistics firm Kühne+Nagel advanced.
Swiss Market Index shifts to 40% pharma weight after latest rebalancing
Healthcare now dominates the SMI after recent additions, raising concentration concerns but offering diversification within the sector itself.
UBS ranks Switzerland’s most desirable residential locations
UBS study finds medium-sized Swiss cities outperform large urban centers on cost and livability, with Freiburg, Solothurn and Aarau leading in affordability. Nine of ten regions favor mid-sized towns over metropolises.
Amrize CFO exits after five months as shares hit record low
Sam Poletti named successor to Baris Oran at struggling Swiss building materials group after shares breach key support. Investor pressure mounts amid inflation and margin concerns.
Swiss SMI edges up 0.12% as Roche, Novartis weigh on blue chips
Amrize and Holcim lead gains in the SMI, while Stadler Rail surges 22% on strong half-year results. US PCE inflation ticks up to 3.7%, lifting September Fed hike odds to 40%.
Swiss changes in September: Gotthard tunnel closures, dog bans and wage hikes
Switzerland implements new regulations including Gotthard tunnel night closures, a dog ban in Schwyz offices, Basel-Stadt wage increases, and revised federal prosecutorial rules. Ebookers halts Swiss bookings.
Swiss equities flat as Logitech, ABB rise; Amrize falls on CFO exit
The SMI traded little changed Tuesday, with Logitech and ABB leading gains while Amrize slumped after its finance chief departed. Swiss franc weakened against the dollar and euro as regional markets tracked mixed European cues.
UBS pushes for softer AT1 capital rules amid Swiss bank reform debate
Swiss lawmakers weigh compromise on Additional-Tier-1 debt as UBS-backed study argues for earlier loss-absorption triggers. Next vote set for Aug. 31.
Swiss stocks mixed as SMI edges higher; Arbonia plunges on earnings
ABB gains led gains among large caps while Arbonia slumped 9.8% after results; UBS and Vontobel adjusted ratings and price targets for several Swiss equities. The Swiss franc weakened further against the dollar and euro.
Swiss stocks rise as SMI nears record; Roche, Novartis lag; U.S. futures mixed
Swiss Market Index climbs 0.5% as construction shares lead gains; SAP downgraded by UBS despite raised price target. U.S. futures diverge ahead of Nvidia earnings and key data.
Swiss stocks fall 1.1% as heavyweights weigh; Partners Group leads gains
Defensive Swiss equities lagged as the SMI slipped 1.1% to 14,384 amid profit-taking ahead of Jackson Hole. Partners Group surged 2.2% while Nestlé, Novartis and Roche declined.
Helvetia launches mid-tier auto insurance covering total loss after collisions
New 'Totalschadenkasko' policy offers partial coverage plus total-loss protection after self-inflicted crashes at roughly one-third the cost of full collision insurance, Helvetia says. Demand strongest among owners of 10-year-old vehicles priced around 44,000 francs when new.
Swiss SMI dips 1% as Nestlé, Novartis, Roche weigh; Gurit surges 10%
Heavyweights drag Switzerland’s blue-chip index lower while Gurit jumps on strong earnings. Investors eye Jackson Hole for Fed clues amid elevated inflation and geopolitical risks.
Swiss SMI falls 0.8% as Nestlé, Novartis, Roche weigh; Gurit jumps 10%
Defensive heavyweights drag Switzerland's blue-chip index lower while chip-linked stocks rise on Nvidia earnings. Brent and WTI oil prices drop over 6% in a week amid Hormuz Strait talks.
UBS study: Mid-sized Swiss cities more attractive for families than Zurich, Geneva
Lower living costs and strong infrastructure in smaller urban centers outweigh benefits of major cities, UBS research finds. Study examines 10 Swiss regions with a two-child family model.
Kantonalbank expansion must be strategic, not just for growth: expert
Reto Jauch warns Swiss regional banks against expansion for its own sake, citing governance and strategic discipline as critical to success amid rising competition and technological change.
Swiss stocks rise pre-market; Accelleron surges on Nvidia-linked demand
SMI futures up 0.08% as Accelleron leads gains after strong half-year results. Brent and WTI oil drop over 1% on Hormuz Strait opening talks. Nvidia’s AI-driven rally boosts semiconductor suppliers.
Swiss equities rise as SMI gains 0.14% amid mixed sector moves
The Swiss Market Index advances modestly, supported by lower oil prices and U.S. equity strength. SoftwareOne and Stadler Rail shares surge on earnings beats, while Amrize leads decliners after record low.
SoftwareOne posts 68% revenue jump, Crayon integration nears completion
Swiss cloud and software provider SoftwareOne reports strong H1 2026 results, with revenue up 68% to CHF818M, though organic growth adjusted for Crayon stands at 11.6%. Net profit rises to CHF70.6M, EBITDA margin expands to 28.9%.
Swiss canton rejects plan to redistribute BLKB profits to municipalities
Baselland government opposes initiative to divert one-third of Basellandschaftliche Kantonalbank earnings to local communities, citing risk exposure and lack of ownership.
UBS-CFA indicator rises but uncertainty over Swiss economy grows
Swiss economic sentiment improves for second month, yet expectations diverge sharply; U.S. outlook darkens while SNB seen holding rates at zero. Euro seen above 0.90 CHF with 79% probability.
Stadler Rail posts record H1 2026 revenue but shares drop 22%
Swiss train maker Stadler Rail reported a 40% revenue jump to CHF 1.96 billion in H1 2026, yet its shares fell 22% as investors focused on weaker margins and negative free cash flow.
Swiss SMI gains 0.5% as construction, tech stocks lead gains
SMI advances toward record high as Amrize, Holcim and Stadler Rail surge; Roche and Novartis weigh on index. Nvidia earnings awaited after U.S. and Asian gains.